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INTRODUCTION
Idiopathic thrombocytopenic purpura (ITP) is an autoim-
mune disorder characterized by a low platelet count and
mucocutaneous bleeding (1). The incidences of atheroscle-
rosis and myocardial infarction in patients with congenital
coagulation disorders and chronic thrombocytopenia are
very low (2). Even though thrombotic events occur in patients
with chronic ITP, most cases were reported during or shortly
after intravenous immunoglobulin (IVIG) administration,
when platelet counts began to rise (3, 4). 
Thrombolytic therapy is contraindicated for a patient with
ITP even with acute myocardial infarction (AMI) (5). Few
cases of primary percutaneous coronary intervention (PCI)
for AMI in patients with ITP have been reported (6, 7).
This report describes a case of AMI that occurred during
thrombocytopenia in a patient with ITP and managed suc-
cessfully by PCI without major bleeding complications. 
CASE REPORT
A 47-yr-old woman was transferred to the emergency room
with anterior chest pain. Three years ago, she was diagnosed
as chronic ITP. The patient has taken steroids for ITP and an
antidiabetic drug for type 2 diabetes mellitus (DM). Because
the patient was diagnosed as type 2 DM only after she took
steroids, probably, it was regarded as drug-induced DM. Chest
pain had developed 6 hr before an arrival at emergency room,
and she had already been treated with nitroglycerin and beta
blocker at other hospital. Electrocardiogram (ECG) showed
ST segment elevation in the leads of II, III, and aVF, which
was consistent with an inferior wall AMI (Fig. 1). The patient
was alert, her blood pressure was 140/90 mmHg with a pulse
rate of 78 beats per minute, and respiration at the rate of 21
per minute. Heart sounds were normal without gallop sound
or significant murmur. The cardiac enzymes were elevated:
the level of CK was 520 U/L (normal range: 20-180 U/L)
and CK-MB 109 U/L (normal range: 0-6 U/L). Platelet count
was 21,000/ L. Blood coagulation tests showed prothrom-
bin time (PT) of 9.75 sec (international normalized ratio
[INR]; 0.76) and activated partial thromboplastin time (aPTT)
of 30.6 sec. Chest radiography showed no pulmonary con-
gestion with cardiothoracic ratio of 50%. 
Urgent diagnostic coronary angiography revealed total
occlusion in the proximal right coronary artery (RCA) (Fig.
2A), and normal left coronary artery (LCA). Loading dose of
clopidogrel (300 mg) was administered and then PCI was
performed using a balloon and a stent for the proximal RCA
lesion successfully (Fig. 2B). During the PCI, temporary
pacemaker was inserted due to sinus arrest. 
Bolus injection of 2,000 units heparin was done at the be-
ginning of the coronary angiography and then additional
6,000 units during the PCI. Activated partial thromboplas-
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Primary Percutaneous Coronary Intervention for Acute Myocardial
Infarction with Idiopathic Thrombocytopenic Purpura
: A Case Report 
Acute myocardial infarction (AMI) is rare in patients with idiopathic thrombocytopenic
purpura (ITP). We describe a case of an AMI during thrombocytopenia in a patient
with chronic ITP. A 47-yr-old woman presented with anterior chest pain and a low
platelet count (21,000/ L) at admission. Urgent coronary angiography revealed
total occlusion of proximal right coronary artery and primary percutaneous coronary
intervention (PCI) was performed successfully. This case suggests that primary
PCI may be a therapeutic option for an AMI in patients with ITP, even though the
patient had severe thrombocytopenia.
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tin time was within normal range (42.8 sec). On the next
day, platelet count was 18,000/ L and ecchymoses were found
around the puncture site of the right femoral artery. Heparin
was not administered any more in the intensive care unit
after the PCI, but combined anti-platelet therapy (aspirin
200 mg and clopidogrel 75 mg) was performed as usual.
IVIG administration was started to prevent hemorrhagic
complications. After the removal of the sheath introducers
from the right femoral artery, we compressed the puncture
sites for more than 30 min to achieve complete hemostasis.
No other bleeding complications occurred. The patient was
discharged asymptomatically at ten days after PCI. 
DISCUSSION
Atherosclerosis and myocardial infarction are rare in patients
with chronic thrombocytopenia. In other words, high platelet
count has been correlated with high incidence of ischemic
heart disease, as well as elevated hemostatic factors (8). If a
patient with chronic thrombocytopenia has a coronary artery
disease, concomitance of known coronary risk factors such as
family history for cardiovascular disease, hypertension, dia-
betes, dyslipidemia, or cigarette smoking, should be consid-
ered. In this case, the patient was obese and had diabetes
after steroid treatment for ITP. Steroids are known to induce
metabolic changes as well as a hypercoagulable state, each
of which may promote atherosclerosis, thus steroids may
play a possible role in precipitating the clinical events in this
patient (8).
IVIG therapy for ITP has been associated with a very rare
occurrence of thrombotic events, such as myocardial infarc-
tion and stroke. Paolini et al. (3) suggested that the rapid
rise in platelet counts in response to IVIG therapy in ITP
may aggravate the potentially adverse effect of increased
plasma viscosity leading to increased susceptibility to fatal
thrombotic events. When a patient with ITP needs IVIG
therapy for thrombocytopenia, careful attention must be
paid to a rapid rise in the platelet count, which may induce
myocardial infarction or stroke, particularly in the elderly
and in patients with coronary risk factors. In this case, AMI
occurred before the patient was treated with IVIG.
Because there is an antigenic mimicry between platelets
and endothelial cells, the pathogenesis of AMI in thrombo-
cytopenic patients with chronic ITP may stem from endothe-
lial damage induced by autoantibodies directed against anti-
gens presented on both platelets and coronary endothelial
cells (9). In this case, the result of platelet associated antigen
was weakly positive. Further studies about the relationship
Fig. 1. Electrocardiogram shows the first degree atrioventricular
block and ST segment elevation in leads of II, III, and aVF.
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Fig. 2. Coronary angiography of the right coronary artery on left anterior oblique view. (A) Total obstruction in the proximal right coronary
artery before percutaneous coronary intervention (PCI). (B) After the PCI with the aid of temporary pacemaker, successful reperfusion was
obtained without residual stenosis.
A Bbetween coronary endothelial cell and platelet associated
antigen are needed to confirm this hypothesis.
This case reminds us of several precautions in managing a
patient with ITP who had AMI during thrombocytopenia.
First of all, when puncturing the vessels to insert a sheath
introducer, it is important not to injure the vessels and be
sure to compress the puncture site for longer than usual after
removing the sheath introducer. Percutaneous closing device
can be used after PCI, especially in patients with coagulation
disorders. Second, there is no recommended dose of heparin
in managing an AMI in a patient with ITP, because of extre-
mely rare occurrences of AMI in ITP. We used cautiously
small amount of heparin before and during the procedure
and IVIG to prevent bleeding complications. Fortunately,
there was no specific bleeding complications related to the
procedure. Although we did not use conventional dose of
heparin, it was enough to manage the patient with AMI dur-
ing thrombocytopenia. Maybe, small dose of heparin with
IVIG therapy can be recommended to treat AMI during
thrombocytopenia. Large investigational study should be
needed in patients with ITP to find out the optimal dose of
heparin. Consequently, the current case suggests that pri-
mary PCI can be a useful therapeutic strategy in acute ST
elevation myocardial infarction.
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